Anthera Pharmaceuticals, Inc.
| Nasdaq: ANTH
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF. Its other product candidate includes varespladib and varespladib sodium, which provides treatment for the patients who have acute coronary syndrome and acute chest syndrome associated with sickle cell disease. Anthera Pharmaceuticals was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.